- Home
- CNTA vs CVSA Comparison
CNTA vs CVSA Comparison
Compare CNTA & CVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNTA | CVSA |
|---|---|---|
| Founded | 2020 | 1987 |
| Country | United Kingdom | United States |
| Employees | N/A | 4996 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Consumer Services |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 3.9B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | CNTA | CVSA |
|---|---|---|
| Price | $39.44 | $115.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $43.17 | ★ $150.00 |
| AVG Volume (30 Days) | ★ 3.0M | 220.4K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.13 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,000,000.00 | N/A |
| Revenue This Year | N/A | $9.66 |
| Revenue Next Year | N/A | $6.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.95 | $96.08 |
| 52 Week High | $40.26 | $119.23 |
Technical Indicators
Market Signals| Indicator | CNTA | CVSA |
|---|---|---|
| Relative Strength Index (RSI) | 73.10 | 53.72 |
| Support Level | $39.16 | $110.97 |
| Resistance Level | $40.26 | $119.02 |
| Average True Range (ATR) | 0.19 | 3.85 |
| MACD | -0.48 | -0.59 |
| Stochastic Oscillator | 59.18 | 65.04 |
Price Performance
Historical ComparisonAbout CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage biotechnology company pioneering a new class of therapeutics in orexin-based neuroscience. The group is developing a franchise of small molecule orexin receptor 2 (OX2R) agonists designed to address neuroscience diseases underpinned by dysregulation of wakefulness, attention, cognition, mood, and other symptoms, each grounded in the shared biology of the orexin pathway. The company's programs and Pipeline are the Orexin Receptor 2 Agonist Program and LockBody Technology Platform.
About CVSA Covista Inc. Common Shares
Covista Inc is an American healthcare educator, serving more than 97,000 students and supported by a community of alumni across five accredited institutions. Through personalized, tech-enabled education powered by faculty and colleagues, it expands access to healthcare careers and addresses the U.S. healthcare workforce shortage at scale.